Maladaptive trained immunity in viral infections
Journal of Clinical Investigation · 02.09.2025 · 135 (17)
DOI: 10.1172/jci192469 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.09.2025. Verfasst von Dmitri Sviridov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Virus Diseases, Immunity, Innate, Immunologic Memory. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NHLBI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Trained immunity (TRIM) is a form of long-lasting functional reprogramming of innate immune cells and their progenitors that enhances responsiveness to subsequent stimuli. Although first characterized in myeloid cells, TRIM was recently extended to nonmyeloid cell types, including endothelial and glial cells, which also exhibit stimulus-driven, memory-like behavior. While initially recognized as a protective mechanism, particularly in the context of vaccines and acute infections, TRIM can also become maladaptive, promoting chronic inflammation, immune dysfunction, and disease. This Review focuses on virus-induced TRIM while also addressing microbial, metabolic, and endogenous inducers. We examine key ligands and receptors that initiate TRIM and dissect the associated signaling and epigenetic pathways. Importantly, we argue that maladaptive TRIM arises not from a specific ligand, receptor, or molecular event, but from contextual factors such as stimulus persistence, dose, tissue microenvironment, and preexisting inflammation. The nature of the secondary challenge also shapes whether a trained response is adaptive or maladaptive. We further discuss TRIM induction in the bone marrow, involvement of both myeloid and nonmyeloid cells, and the role of lipid rafts in sustaining TRIM. We review maladaptive TRIM’s potential contribution to systemic diseases, such as atherosclerosis, diabetes, sepsis, cancer, and autoimmunity, along with its influence on viral vaccine responses. Finally, we outline potential strategies to redirect maladaptive TRIM and propose key outstanding questions for future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
- Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia.
- Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, Netherlands.
- Department of Immunology and Metabolism, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany.
- Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Förderung
- NINDS NIH HHS
- NHLBI NIH HHS
- NIAID NIH HHS
Zitieren
APA
Sviridov, D., Netea, M. G., & Bukrinsky, M. I. (2025). Maladaptive trained immunity in viral infections. Journal of Clinical Investigation, 135(17). https://doi.org/10.1172/jci192469
Vancouver
Sviridov D, Netea MG, Bukrinsky MI. Maladaptive trained immunity in viral infections. Journal of Clinical Investigation. 2025;135(17). doi:10.1172/jci192469
BibTeX
@article{Sviridov2025,
author = {Sviridov, Dmitri and Netea, Mihai G and Bukrinsky, Michael I},
title = {Maladaptive trained immunity in viral infections},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {17},
doi = {10.1172/jci192469}
}
EUVIMED